Cases by country, the UK and NHS pathway and other country lenses, the expert centres with trials on record, and the centres named on this cancer's subtypes.
No country-level case numbers. This cancer is not mapped to a GLOBOCAN site.
Bethesda, MD · government | United States | none recorded | 1 | 2,852 | 46,921 | - | |
Durham, NC · cancer center | United States | 0 | 546 | 10,220 | - | ||
Singapore · cancer center | Singapore | none recorded | 0 | 467 | 4,399 | - | |
Indianapolis, IN · cancer center | United States | 0 | 323 | 5,574 | - | ||
Los Angeles, CA · cancer center | United States | 0 | 318 | 3,917 | - | ||
Baltimore, MD · cancer center | United States | 0 | 301 | 4,749 | - | ||
Melbourne · research institute | Australia | none recorded | 0 | 298 | 3,639 | - | |
Omaha, NE · cancer center | United States | 0 | 190 | 5,384 | - | ||
Hamilton, ON · cancer center | Canada | none recorded | 0 | 126 | 1,460 | - | |
Singapore · hospital | Singapore | none recorded | 0 | 96 | 2,522 | - | |
Minneapolis, MN · cancer center | United States | 0 | not matched | - | - | ||
Shanghai · hospital | China | none recorded | 0 | not matched | - | - |
These are the things we can measure; they are not a ranking of quality. Each column is a field on the institution record or a count over what OnCo has linked; a centre that treats many patients with IDH1- and IDH2-mutated acute myeloid leukaemia but is thinly recorded here will look small.
Not known: OnCo holds no case-volume or outcome figures for centres, so none are shown. Where a national audit or registry publishes them, the centre's page links to it. Default order: Newsweek rank, then trials for this cancer, then research output.